Insider · CIK 0001879223
Juan Graham
Files at CATX (Perspective Therapeutics, Inc.), KYNB (KYNTRA BIO, INC.). First filing Apr 1, 2025, latest Apr 1, 2025.
Juan Graham files SEC Form 4 as CFO at CATX (Perspective Therapeutics, Inc.), and also at KYNB (KYNTRA BIO, INC.). Since Apr 1, 2025, Juan Graham has reported 1 open-market buy worth $75k and 0 open-market sells worth $0, the latest filed on Apr 1, 2025.
A track record needs three past buys with six months of prices behind them; Juan Graham has 0, so none is measured yet.
The newest scored trade: bought $75k of CATX on Mar 28, 2025, filed Apr 1, 2025, scored 73 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CATX: Perspective Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 73Notable | Perspective Therapeutics, Inc. | $75k 33,333 shares | +1649% | 0% from low-86% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +33,333 | $2.25 | $75k | 35,354 | Apr 1, 2025 |
| Jan 6, 2025 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Jan 7, 2025 |
| Dec 6, 2024 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -1,446 | $0.34 | $495 | 165,929 | Dec 9, 2024 |
| Dec 7, 2024 | KYNB KYNTRA BIO, INC. | FTax withholding Common Stock | -1,066 | $0.34 | $365 | 164,863 | Dec 9, 2024 |
Questions about Juan Graham
Answered from the filings on this page, as of the latest one.
Is Juan Graham buying or selling?
Not in the last 12 months. Juan Graham's latest open-market trade on SEC Form 4 was bought $75k of CATX on Mar 28, 2025.
How did Juan Graham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Juan Graham has 0.
Where does Juan Graham file Form 4?
Juan Graham has filed Form 4 at CATX (Perspective Therapeutics, Inc.) as Chief Financial Officer; KYNB (KYNTRA BIO, INC.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.